Doseology Shifts to Semi-Annual Financial Reporting

• British Columbia Securities Commission revoked Doseology Sciences' management cease trade order, issued October 29, 2026.
• Revocation followed the November 3, 2026, filing of audited financial statements for the year ended June 30, 2026, with related disclosures.
• The company will adopt semiannual financial reporting, eliminating first- and third-quarter financial statements and related management discussion and analysis.
• The change starts with periods ending September 30, 2026, and March 31, 2027.
• Audited annual financial statements and six-month interim financial reports will continue.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Doseology Sciences Inc. published the original content used to generate this news brief via Newsfile (Ref. ID: 202611051630NEWSFILECNPR____20261105_322708_1) on November 05, 2026, and is solely responsible for the information contained therein.